Speaker: John Granton, MD, University of Toronto, ON
Moderator: Paul Hernandez, MDCM, FRCPC, Dalhousie University, Halifax, NS

This presentation will provide the audience with the evidence for early identification of patients with Pulmonary Arterial Hypertension (PAH). It will provide an evidence-based approach to the evaluation of identifying PH in high risk groups and those with an elevated right ventricular systolic pressure (RVSP) on echocardiography to determine patients who would benefit from directed therapies. It will also provide an update on the role of exercise testing in the evaluation of patients with pulmonary hypertension.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Identify and screen high-risk patients for pulmonary hypertension;
  • Evaluate a patient with an elevation in right ventricular systolic pressure (RVSP) and identify those who might benefit from directed therapies; and
  • Integrate exercise testing into the evaluation of patients with suspected or confirmed pulmonary hypertension.

CanMEDS Roles: Collaborator, Communicator, Medical Expert, Professional, Scholar

Click here for session invitation

This session is co-developed by the Canadian Thoracic Society and Janssen and is planned to achieve scientific integrity, objectivity and balance.